Formation of Wild-Type and Chimeric Influenza Virus-Like Particles following Simultaneous Expression of Only Four Structural Proteins

Por Latham, Theresa, Galarza, Jose M.
Publicado em 2001

Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge

Por Nasar, Farooq, Matassov, Demetrius, Seymour, Robert L., Latham, Theresa, Gorchakov, Rodion V., Nowak, Rebecca M., Leal, Grace, Hamm, Stefan, Eldridge, John H., Tesh, Robert B., Clarke, David K., Weaver, Scott C.
Publicado no J Virol (2017)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

Por Mire, Chad E., Matassov, Demetrius, Geisbert, Joan B., Latham, Theresa E., Agans, Krystle N., Xu, Rong, Ota-Setlik, Ayuko, Egan, Michael A., Fenton, Karla A., Clarke, David K., Eldridge, John H., Geisbert, Thomas W.
Publicado no Nature (2015)

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Por Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.
Publicado no Open Forum Infect Dis (2015)